Diverse Team

Our team, With expertise in scientific research areas like nano chemistry, radiation oncology and  degrees in fields such as medicine,  neuroscience, biochemistry, microbiology, engineering and business the SiNON Nano Sciences team is ready to tackle challenges.  Our small size makes us quick, responsive and our experience ensures we can execute and exceed expectations.

Our Leadership Team

Our Leadership team integrates advanced medical innovations and cutting-edge nanosciences to revolutionize patient care.  Their expertise drives pioneering breakthroughs that enhance healthcare outcomes and well-being. With a vision for the future, they are committed to shaping the next generation of medical solutions that empower patients and transform lives globally.

Afreen Allam, MBA in SiNON Nano Sciences

Afreen Allam, MBA

Founder & CEO
With 15 years of expertise in nanomedicine, holding degrees in Microbiology, Biochemistry, and an MBA.

Abdul Allam, MS, MBA in SiNON Nano Sciences

Abdul Allam, MS, MBA

Director of R&D
15 years of experience in Organic Chemistry and Nanotechnology, specializing in the development of carbon nanoparticles and formulations.

Dr. Shihab Maliyekkal, PhD in SINON Nano Sciences

Dr. Shihab Maliyekkal, PhD

Chief Technical Officer
14 years of experience in developing nanotechnology-based water filtration systems.

Dr. Suman Gomosta, PhD in SiNON Nano Sciences

Dr. Suman Gomosta, PhD

Senior Lead Researcher
10 years of experience in developing carbon nanomaterial synthesis.

Dr. Amit Dinda, MD/PhD in SiNON Nano Sciences

Dr. Amit Dinda, MD/PhD

External Research Director
20 years of expertise in immunopathology, tissue engineering, cancer biology, and nanomedicine.

Our Advisors Team

Our Advisors team brings a wealth of knowledge and expertise from various industries. With backgrounds in science, business, and technology, they provide strategic guidance and innovative solutions to help us navigate complex challenges and drive sustainable growth. Their diverse perspectives and forward-thinking approach ensure we remain at the forefront of industry advancements while maintaining our mission of improving patients outcomes.

Dr Kristina Mason, PhD MBA in SiNON Nano Sciences

Dr Kristina Mason, PhD/MBA

Biotech Advisor
Co-Founder of Acrivon

Kenneth Zeitler

Dr Kenneth Zeitler, MD

Physician Advisor
Retired Oncologist

Tage Honore in SiNON Nano Sciences

Tage Honore, PhD, DSc

Pharmacology Advisor
Co-Founder of Aestus Therapeutics

Dr. David Robinson, PhD MBA in SiNON Nano Sciences

Dr. Jeremy Petranka, PhD

Strategy Advisor
Assistant Dean Fuqua School of Business

Julian Rimmer, MBA in SiNON Nano Sciences

Julian Rimmer, MBA

Business Advisor
Associate Director at Abbvie

Nicholas Cox, MBA in SiNON Nano Sciences

Nicholas Cox, MBA

Strategy & Commercialization Advisor
Co-Founder, Pinkston Strategy

Dr. David Robinson, PhD MBA in SiNON Nano Sciences

Dr. David Robinson, PhD/MBA

Finance Advisor
Professor Fuqua School of Business

Dr. Michelle Chernock, PhD in SiNON Nano Sciences

Dr. Michelle Chernock, PhD

Pharma Advisor
Former Head of Neuroscience at Novartis

Matthew Brunnette, MBA in SiNON Nano Sciences

Matthew Brunnette, MBA

Strategy & Commercialization Advisor
Managing Partner, East Harriet Advisors